Alnylam Pharmaceuticals Inc (ALNY)
148.43
-1.60
(-1.07%)
USD |
NASDAQ |
May 31, 16:00
148.43
0.00 (0.00%)
After-Hours: 20:00
Alnylam Pharmaceuticals Gross Profit (Quarterly): 428.36M for March 31, 2024
Gross Profit (Quarterly) Chart
Historical Gross Profit (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 428.36M |
December 31, 2023 | 353.86M |
September 30, 2023 | 666.22M |
June 30, 2023 | 233.38M |
March 31, 2023 | 264.42M |
December 31, 2022 | 283.77M |
September 30, 2022 | 223.19M |
June 30, 2022 | 184.01M |
March 31, 2022 | 177.63M |
December 31, 2021 | 220.87M |
September 30, 2021 | 154.97M |
June 30, 2021 | 181.80M |
March 31, 2021 | 146.50M |
December 31, 2020 | 140.54M |
September 30, 2020 | 104.06M |
June 30, 2020 | 84.03M |
March 31, 2020 | 86.17M |
December 31, 2019 | 59.50M |
September 30, 2019 | 64.85M |
June 30, 2019 | 40.39M |
March 31, 2019 | 29.95M |
December 31, 2018 | 19.37M |
September 30, 2018 | 1.932M |
June 30, 2018 | 29.91M |
March 31, 2018 | 21.90M |
Date | Value |
---|---|
December 31, 2017 | 37.92M |
September 30, 2017 | 17.10M |
June 30, 2017 | |
March 31, 2017 | |
December 31, 2016 | |
September 30, 2016 | |
June 30, 2016 | |
March 31, 2016 | |
December 31, 2015 | |
September 30, 2015 | |
June 30, 2015 | |
March 31, 2015 | |
December 31, 2014 | |
September 30, 2014 | |
June 30, 2014 | |
March 31, 2014 | |
December 31, 2013 | |
September 30, 2013 | |
June 30, 2013 | |
March 31, 2013 | |
December 31, 2012 | |
September 30, 2012 | |
June 30, 2012 | |
March 31, 2012 | |
December 31, 2011 |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Quarterly) Range, Past 5 Years
40.39M
Minimum
Jun 2019
666.22M
Maximum
Sep 2023
204.93M
Average
179.72M
Median
Gross Profit (Quarterly) Benchmarks
Pfizer Inc | 11.50B |
BridgeBio Pharma Inc | 210.52M |
Cytokinetics Inc | -80.74M |
Ionis Pharmaceuticals Inc | 117.35M |
Madrigal Pharmaceuticals Inc | -- |